Skip to content

Anaptysbio, Inc

ANAB· NasdaqCore metricsCIK 1370053

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.25%
Market cap
$1.42B
29.73M shares
Filings
728
$30.27M
Q1 2027+157.0% FY25 yoy
$3.88M
Q1 2027N/M FY25 yoy
$19.91M
Q1 2027N/M FY25 yoy
-$25.94M
Q1 2026derivedN/M FY25 yoy
$0.11
Q1 2027N/M FY25 yoy
$135.39M
Q1 2027−43.8% FY26 yoy
$1.42B
—
6.1×
68.2×
1.38%
—

FY2025 figures · derived

Price

$47.77+42.33%+$14.20past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$234.60MFY 2025
$234.60M0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$234,603,000reported
FY 20242024-12-31$91,280,000reported
FY 20232023-12-31$17,157,000reported
FY 20222022-12-31$10,287,000reported
FY 20212021-12-31$63,175,000reported
FY 20202020-12-31$75,000,000reported
FY 20192019-12-31$8,000,000reported
FY 20182018-12-31$5,000,000reported
FY 20172017-12-31$10,000,000reported
FY 20162016-12-31$16,684,000reported
FY 20152015-12-31$17,571,000reported

Capital returns

Dividends and buybacks · FY2015 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$68.63M$68.63M—29.10M sh−5.1%350.0%
FY2024—$456.00K$456.00K—30.67M sh+14.6%—
FY2023—$50.00M$50.00M—26.76M sh−4.2%—
FY2022—$0.00$0.00—27.93M sh+0.9%—
FY2021—$0.00$0.00—27.67M sh+1.1%—

Segments

Segments
Revenue by Segments, FY2022 to FY2025FY2022Reportable Segment · FY2022 · $10.29MFY2023Royalty Management · FY2023 · $17.16MReportable Segment · FY2023 · $17.16MFY2024Royalty Management · FY2024 · $91.28MReportable Segment · FY2024 · $91.28MFY2025Royalty Management · FY2025 · $234.60M
LineFY2025ShareChange
Royalty Management$234.60M100%+157.0%
Biopharma$0.00——
Reportable Segment———
Total$234.60M

From the 10-K filed Mar 3, 2026ANAB

Pharmaceutical preparations

Anaptysbio, Inc is the 80th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Anaptysbio, Inc · CIK 1370053 · Engraved from SEC EDGAR